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Abstract — Aims: Alcohol dependent patients in withdrawal display a wide spectrum of neurological and neuropsychological symp-
toms that complicate diagnosis. We report the case of a 53-year-old male alcoholic with disorientation, ataxia and nystagmus in alcohol
withdrawal probably due not to initial supposed Wernicke’s encephalopathy (WE) but rather due to multiple cerebral metastases of a
non-small cell cancer of the lung. Results: The findings illustrate the importance of initially maintaining a tentative attitude toward
causation of symptoms and the role of brain imaging in formulating an accurate diagnosis.
Alcohol dependent patients in withdrawal can demonstrate
a wide spectrum of neurological and neuropsychological
symptoms and sometimes pose great challenge to physicians.
Mr A was a 53-year-old undernourished, unemployed, cook
who had been transferred to our clinic by a general practitioner
due to confusion and disorientation with the onset of acute
symptoms a few days before admission. A diagnosis of intox-
ication due to inadvertent high intake of prescribed medication
(ranitidine, lansoprazole, propyphenazone and drofenin) and
ethanol had been made.
Mr A had a history of alcohol dependence of 30 years
duration with three previous treatments for alcohol with-
drawal. He had been admitted to our clinic 3 years before,
when oxazepam was prescribed for alcohol withdrawal symp-
toms. Due to poor compliance, he only stayed 3 days. He did
not agree with a rehabilitation program for maintenance of
abstinence. After discharge he recommenced consuming alco-
hol in large quantity.
The first time Mr A was admitted to our clinic, by his
general practitioner because of uncontrolled alcohol con-
sumption, in the same year the detoxification treatment with
a rehabilitation program (55 days) was complicated due to
a general tonic–clonic epileptic seizure. Along with
oxazepam, he received antiepileptic therapy with carba-
mazepine. The third hospitalization was one year before the
present admission and lasted for 56 days followed by four
months of intensive rehabilitation program in a clinic outside.
Mr A had also been dependent on benzodiazepines (75 mg
oxazepam/day and an unknown dose of bromazepam) for the
past 3 years and nicotine for 35 years at a level of 70–100
pack years (Fagerstrom score: 9). Six years prior to the final
admission he had undergone excision of pancreatic pseudo
cysts as complication of a chronic pancreatitis.
We usually recommend all alcohol-dependent patients
600 mg thiamine, 30 mg riboflavin, 20 mg pyridoxine, 20 mg
cobalamine, 0.3 mg biotine, 50 mg panthotenacid, and
100 mg nicotinamid orally per day for vitamin supplementa-
tion, but Mr A did not agree to vitamin therapy.
During the three past hospitalization periods of overall
114 days Mr A received orally only on 19 days, 600 mg
thiamine/day for vitamin supplementation. The patient had
also not taken vitamin supplements outside of our clinic.
At admission, his height was 173 cm and his weight 52 kg,
corresponding with a body mass index of 17 kg/m2 (age-
adjusted reference of the body mass index 22–27). Clinical
signs of vitamin deficiency such as disturbance of nails or
hair growth were not detectable. His wife reported that he
had consumed alcohol daily during the four months before
admission.
Mr A was awake but disorientated to person, location, situ-
ation, and time. Reduced attention and short memory deficit
were readily observable. Thought disturbance, phobia, com-
pulsion, delusions, hallucinations, and depersonalisation
were not detectable. His affect was slightly dysphoric and he
was restless as well as impulsive. He denied suicidal ideation.
In the Mini-Mental-State test (MMS) (Folstein et al., 1975) he
achieved a score of 15 out of 30 points.
Neurological examination revealed gaze-evoked nystagmus
in all directions. Meningism was not found. No abnormal
functioning of the other cranial nerves, paralysis or sense
disturbances were detected. All deep tendon reflexes were
symmetrically elevated. Pathological reflexes were not detect-
able. The finger–nose test was atactic. Standing and gait with
open eyes evidenced a distinct non-directional ataxia with tre-
mors of the upper extremity. The Romberg sign was positive.
Apart from a slightly elevated gammaglutamyl transferase
(GGT) (94 U/l; reference 11–66 U/l) and mean corpuscular
hemoglobin (MCH) (32 pg; reference 27–31 pg), routine
blood parameters including hemogram, chemogram, coagula-
tion, C-reactive protein, and ammoniac were normal.
Confusion, ataxia, and nystagmus suggested acute
Wernicke’s encephalopathy (WE). He received 100 mg thiam-
ine intramuscular directly after neurological examination
(Day 0). Simultanously, we applied for neuro-imaging for
exclusion of other possible causes of the very distinctive
disorientation and ataxia. On the next day his status had not
improved. Cranial computed tomography revealed multiple
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infra- and supra-tentorial, hyperdense, space-occupying,
maximally sized 4.5 cm lesions with distinctive perifocal
oedema, central hypodensity, and compression of the side ven-
tricle due to elevated intracerebral pressure (Fig. 1), indicating
possible metastases. The corpora mamillaria were not hypo-
trophic. Magnetic resonance tomography imaging was not
possible due to the patient’s poor compliance.
To locate the primary tumor, computed tomography of
thorax was performed and revealed a space occupying lesion
in the left pulmonal hilus between the bronchus of the lingula
and lower lobe with mass effect and dorsal replacement of the
vessels without hints of angio-invasion (Fig. 2).
Skeletal scintigraphy showed multiple diffused elevated
enhancements particularly in the ribs suggesting multiple
bone metastases. The diagnosis of a less differentiated malig-
nant non-small cell bronchial carcinoma was corroborated by
bronchoscopy and transbronchial biopsy.
Multidisciplinary therapy was planned with radiotherapy,
oncology, neurology, and psychiatry. After beginning pallia-
tive radiation treatment on Day 15, disorientation and gait
disturbances initially became much worse. We used repeated
doses of 10–20 mg haloperidol as reserve medication for
agitation and 175 mg fentanyl for skeletal pain. The patient
declined further vitamin supplementation. From Day 46,
Mr A received prednisone 100 mg/day to reduce brain
edema. In the following days, the neurological and neuropsy-
chological symptoms improved markedly. On Day 61, the
patient was discharged with significantly improved disorienta-
tion, pain, and gait ataxia, receiving palliative medication,
prednisone 100 mg/day and fentanyl 175 mg/day. He was
orientated to person, location, and situation, but not to
time. He was able to stand alone and walk with help.
He died about 2 months after his discharge in the circle of
his family.
DISCUSSION
To the best of our knowledge, this is the first case reporting
multiple intracerebral metastases in a chronic alcoholic with
observable signs of WE.
WE is an acute, preventable, life-threatening metabolic
disease of the central nervous system caused by thiamine
deficiency. Thiamine dependent enzymes such as transketo-
lase and pyruvate dehydrogenase are essential for cerebral
myelinization. WE is probably caused by decreased energy
metabolism caused by citric acid cycle disturbance, and
decreased synthesis of neurotransmitter such as acetylcholine
(McCandless et al., 1969). Thiamine deficiency and WE
may occur in anorexia nervosa, hyperemesis gravidarum,
small-bowel obstruction, AIDS, dialysis, prolonged intra-
venous feeding, or other conditions associated with prolonged
poor intake (Reuler et al., 1985; Homewood et al., 1999;
Togay-Isikay et al., 2001; Ogershok et al., 2002). However,
malnourishment is the most common basis for WE in alco-
holics. The daily thiamine requirement for healthy individuals
is between 1 and 2 mg/day but both alcohol and malnutrition
may interfere with the absorption of thiamine (Thomson
et al., 2006a). Already 17 years ago, Gastaldi et al. (1989)
found that ethanol can damage the intestinal mucosa of rats
with consecutive thiamine malabsorption. Low plasma levels
of thiamine have been reported in up to 80% of alcoholic
patients (Cook et al., 1998).
Autopsy studies reveal that WE is often under-diagnosed:
Naidoo et al. (1991) found histological changes of WE in
17 out of 29 consecutive alcohol-related deaths. The classical
clinical triad of WE are oculomotor findings, ataxia, and
mental confusion (Reuler et al., 1985). Typically, oculomotor
deficits include weakness of abduction, gaze-evoked
nystagmus, internuclear ophthalmoplegia, vertical nystagmus
in primary position, and decreased vestibule-ocular-reflex.
The oculomotor finding in Mr A was an omni-directional
gaze-evoked nystagmus.
It is difficult to diagnose WE clinically since only a third of
the cases display the classical triad symptoms. Clinical signs
can be masked by level of consciousness or other neurological
symptoms (Harper, 1983; Reuler et al., 1985). Due to the
variable symptom-pattern of WE, the possibility of thiamine
deficiency should be considered in any patient with docu-
mented or suspicious history of alcoholism showing any
neurological features including even coma (Wallis et al.,
1978). Thiamine should also be supplemented fully in mal-
nourished alcoholics. The administration of intravenous fluids
containing glucose without adequate thiamine supplementa-
tion in alcoholics could aggravate the thiamine deficiency
leading to irreversible cerebral lesions and death (Yokote
et al., 1992; Koguchi et al., 2004).
In 1997 Caine et al. (1997) developed improved operational
criteria for the diagnosis of WE in alcoholics: WE can be
identified by the presence of malnourishment, oculomotor
abnormalities, cerebellar dysfunction, memory impairment,
or altered mentation. Mr A demonstrated all of these criteria.
Fig. 1. Axial cranial computed tomography with contrast injection (slide
thickness 3 mm): multiple round, cystic space occupying lesions with central
hypodensity, perifocal edema, mass effect and marginal contrast enhancement
frontal, fronto-temporal and parietal. Maximal size: 4.5 cm.
Fig. 2. Thoracal computed tomography with contrast injection (slide thick-
ness 7 mm): space occupying lesion in the left hilus, central discrete dorsal
replacement of the vessels.
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During recent years, brain imaging has proved useful in
confirming the diagnosis of WE and in contributing to earlier
detection (Antunez et al., 1998). The usual findings at MR
imaging in patients with WE include high signal intensities
in the mamillary bodies, medial thalami, tectum of the
midbrain, and the periaqueductal region. The chronic stage
may show atrophy of of the mamillary bodies and midbrain
tegmentum, as well as dilatation of the third ventricle
(Yokote et al., 1991; Doraiswamy et al., 1994). Unfortunately,
we could not perform MRI in our patient due to poor
compliance.
Although we have not determined plasma thiamine level
as it is not a routine parameter on admission we believed
that Mr A’s initial symptoms were not due to WE but due to
the multiple brain metastases. There are some hints that
support this hypothesis. First, due to poor compliance Mr A
got only one administration of 100 mg thiamine intramuscular.
Intramuscular doses of >200 mg daily are believed to be
required to show improvement in disorientated WE-patients
(Ambrose et al., 2001; Thomson et al., 2002). Second, the
neuropsychological improvement of Mr A occurred too late
to attribute it to the administration of thiamine: Mr A received
a singular dose of 100 mg thiamine on admission day and
improved after the Day 46. We attributed his eventual neuro-
logical and neuropsychological improvement to the palliative
whole brain radiation therapy (WBRT) and prednisone
treatment. The initial worsening of neurological symptoms is
typical for WBRT. WBRT is the treatment of choice for brain
metastases because it prolongs the mean survival rate from
1 to 6 months (Zabel et al., 2004), affords a good local control,
eliminates any micrometastases, reduces the risk of recurrent
brain metastases, improves overall survival and quality of
life as in our case, and can prevent death due to brain compres-
sion syndrome (Ellis et al., 1998).
Mr A’s case demonstrates that the clinical criteria for WE
are not pathognomic. The spectrum of differential diagnoses
is quite broad and includes intracranial haemorrhage, stroke,
brain tumor, intracerebral metastases, hepatic failure, central
pontine myelinolysis, as well as, cerebral infections such as
meningitis. According to recent published recommendations
it is good clinical practice that patients at risk of WE receive
250 mg thiamine intramuscular for 3–5 days (Thomson et al.,
2006b) but if there is no rapid response, further neurological
examination are required in order to establish the correct diag-
nosis and serve optimal medical treatment.
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